Get started
Author

Ishita Barat Sen

Observed names: I. Sen, I. Şen, Ishita B Sen, Ishita B. Sen, Ishita Sen, IshitaB Sen
ORCID: 0000-0001-5883-0865
Observed ORCID: 0000-0001-5883-0865
OpenAlex ID: A5022689085
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
2024 · Mike M Sathekge, Ismaheel O Lawal, et al. · The Lancet Oncology · 222
Potential role of F18 FDG PET-CT as an imaging biomarker for the noninvasive evaluation in uncomplicated skeletal tuberculosis: a prospective clinical observational study
2014 · Sugandha Dureja, Ishita Barat Sen, et al. · European Spine Journal · 67
Role of 18F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma
2013 · Vineet Pant, Ishita B. Sen, et al. · Nuclear Medicine Communications · 43
Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy
2021 · Ishita Sen, Parul Thakral, et al. · Annals of Nuclear Medicine · 42
Successful Management Of Tumor‐Induced Osteomalacia with Radiofrequency Ablation: A Case Series
2019 · Sunil Kumar Mishra, Mohammad Shafi Kuchay, et al. · JBMR Plus · 42
PDF
Dosimetric analysis of patients with gastro entero pancreatic neuroendocrine tumors (NETs) treated with PRCRT (peptide receptor chemo radionuclide therapy) using Lu-177 DOTATATE and capecitabine/temozolomide (CAP/TEM)
2018 · Parul Thakral, Ishita Sen, et al. · British Journal of Radiology · 33
Potential Efficacy of 68Ga-Trivehexin PET/CT and Immunohistochemical Validation of αvβ6 Integrin Expression in Patients With Head and Neck Squamous Cell Carcinoma and Pancreatic Ductal Adenocarcinoma
2024 · Subha Shankar Das, Sunita Ahlawat, et al. · Clinical Nuclear Medicine · 32
Prospects of medium specific activity 177 Lu in targeted therapy of prostate cancer using 177 Lu‐labeled PSMA inhibitor
2016 · Sudipta Chakraborty, Rubel Chakravarty, et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 28
Rare sites of metastases in prostate cancer detected on ga-68 psma pet/ct scan—a case series
2017 · Ishita Sen, Sugandha Dureja, et al. · Indian Journal of Nuclear Medicine · 25
Dosimetric analyses of intra-arterial versus standard intravenous administration of 177Lu-DOTATATE in patients of well differentiated neuroendocrine tumor with liver-dominant metastatic disease
2021 · Parul Thakral, Ishita Sen, et al. · British Journal of Radiology · 23
PDF
False Positive 18F-FDG PET Scan in Adrenal Oncocytoma
2008 · C. Acar, B.E. Akkas, et al. · Urologia Internationalis · 16
Osteoporosis in Indian women aged 40–60 years
2010 · Shankar Acharya, Abhishek Srivastava, et al. · Archives of Osteoporosis · 15
The Role of PET-CT-Guided Metabolic Biopsies in Improving Yield of Inconclusive Anatomical Biopsies: A Review of 5 Years in a Teaching Hospital
2023 · Dharmender Malik, Vineet Pant, et al. · Diagnostics · 14
PDF
Incremental value of Ga-68 prostate-specific membrane antigen-11 positron-emission tomography/computed tomography scan for preoperative risk stratification of prostate cancer
2020 · Ishita Sen, UN Pallavi, et al. · Indian Journal of Nuclear Medicine · 14
Molecular imaging to the surgeons rescue: Gallium-68 DOTA-exendin-4 positron emission tomography-computed tomography in pre-operative localization of insulinomas
2019 · Ishita Sen, UN Pallavi, et al. · Indian Journal of Nuclear Medicine · 12
Validation of In-House Kit-Like Synthesis of 68 Ga-Trivehexin and Its Biodistribution for Targeting the Integrin αvβ6 Expressing Tumors
2023 · Parul Thakral, Subha Shankar Das, et al. · Cancer Biotherapy and Radiopharmaceuticals · 9
Invasive Fungal Infection in COVID-19–Recovered Patient Detected on 18F-FDG–Labeled Leukocytes PET/CT Scan
2021 · Divya Manda, Ishita Sen, et al. · Clinical Nuclear Medicine · 8
Incremental Value of 18F-FDG–Labeled Leukocytes PET/CT Over 18F-FDG PET/CT Scan in the Detection of Occult Infection
2022 · Divya Manda, Parul Thakral, et al. · Clinical Nuclear Medicine · 5
Radiation Exposure to the Nuclear Medicine Personnel During Preparation and Handling of 213Bi-Radiopharmaceuticals
2019 · Parul Thakral, Ishita Sen, et al. · Journal of Nuclear Medicine Technology · 5
PDF
Radiation dose to the occupational worker during the synthesis of 188 Re-labeled radiopharmaceuticals in the nuclear medicine department
2018 · Ishita Sen, Parul Thakral, et al. · Indian Journal of Nuclear Medicine · 5
Charting the Course of Targeted α Therapy With First-in-Human, Postadministration Image-Guided Dosimetry and Response Assessment of 212Pb-VMT-α-NET in Metastatic Neuroendocrine Tumors
2024 · Navneet Singh, Nishant Rana, et al. · Clinical Nuclear Medicine · 4
Lead-203 VMT-α-Neuroendocrine Tumor Scintigraphy: A Promising Theranostics Agent
2024 · Parul Thakral, Ishita Barat Sen, et al. · Indian Journal of Nuclear Medicine · 4
Validation of Radiosynthesis and First in-Human Dosimetry of 68 Ga-NOTA-UBI-29-41: A Proof of Concept Study
2024 · Parul Thakral, Nishant Rana, et al. · Cancer Biotherapy and Radiopharmaceuticals · 3
Novel approach in treatment of Burkholderia pseudomallei osteomyelitis: salvage therapy with levonadifloxacin
2025 · Neha Gupta, Vikas Agashe, et al. · JAC-Antimicrobial Resistance · 2
PDF
Radioguided Surgery in Insulinoma Using 68Ga Labeled Exendin-4: a Case Report
2021 · Subha Shankar Das, Parul Thakral, et al. · Nuclear Medicine and Molecular Imaging · 2
Works count: 46
Citation count: 680
H-index: 14
I10-index: 15
Year
Topic
Type